BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29348469)

  • 1. Treprostinil inhibits proliferation and extracellular matrix deposition by fibroblasts through cAMP activation.
    Lambers C; Roth M; Jaksch P; Muraközy G; Tamm M; Klepetko W; Ghanim B; Zhao F
    Sci Rep; 2018 Jan; 8(1):1087. PubMed ID: 29348469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of anti-remodelling action of treprostinil in human pulmonary arterial smooth muscle cells.
    Lambers C; Kornauth C; Oberndorfer F; Boehm PM; Tamm M; Klepetko W; Roth M
    PLoS One; 2018; 13(11):e0205195. PubMed ID: 30383775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Activation of Guanylate Cyclase and Cyclic AMP in Lung Fibroblasts as a Novel Therapeutic Concept for Lung Fibrosis.
    Lambers C; Boehm PM; Karabacak Y; Samaha E; Benazzo A; Jaksch P; Roth M
    Biomed Res Int; 2019; 2019():1345402. PubMed ID: 30984775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged Scar-in-a-Jar: an in vitro screening tool for anti-fibrotic therapies using biomarkers of extracellular matrix synthesis.
    Rønnow SR; Dabbagh RQ; Genovese F; Nanthakumar CB; Barrett VJ; Good RB; Brockbank S; Cruwys S; Jessen H; Sorensen GL; Karsdal MA; Leeming DJ; Sand JMB
    Respir Res; 2020 May; 21(1):108. PubMed ID: 32381012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated Collagen Homeostasis by Matrix Stiffening and TGF-β1 in Fibroblasts from Idiopathic Pulmonary Fibrosis Patients: Role of FAK/Akt.
    Giménez A; Duch P; Puig M; Gabasa M; Xaubet A; Alcaraz J
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29144435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
    Epstein Shochet G; Wollin L; Shitrit D
    Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous Semaphorin-7A Impedes Human Lung Fibroblast Differentiation.
    Esnault S; Torr EE; Bernau K; Johansson MW; Kelly EA; Sandbo N; Jarjour NN
    PLoS One; 2017; 12(1):e0170207. PubMed ID: 28095470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic administration of inhaled INS1009, a treprostinil prodrug formulation, inhibits bleomycin-induced pulmonary fibrosis in rats.
    Corboz MR; Zhang J; LaSala D; DiPetrillo K; Li Z; Malinin V; Brower J; Kuehl PJ; Barrett TE; Perkins WR; Chapman RW
    Pulm Pharmacol Ther; 2018 Apr; 49():95-103. PubMed ID: 29408757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy and the unfolded protein response promote profibrotic effects of TGF-β
    Ghavami S; Yeganeh B; Zeki AA; Shojaei S; Kenyon NJ; Ott S; Samali A; Patterson J; Alizadeh J; Moghadam AR; Dixon IMC; Unruh H; Knight DA; Post M; Klonisch T; Halayko AJ
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L493-L504. PubMed ID: 29074489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of transforming growth factor -β1 on α-smooth muscle actin and collagen expression in equine endometrial fibroblasts.
    Szóstek-Mioduchowska AZ; Lukasik K; Skarzynski DJ; Okuda K
    Theriogenology; 2019 Jan; 124():9-17. PubMed ID: 30321755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-β1 pathway in human lung fibroblasts.
    Schilter H; Cantemir-Stone CZ; Leksa V; Ohradanova-Repic A; Findlay AD; Deodhar M; Stockinger H; Song X; Molloy M; Marsh CB; Jarolimek W
    Immunol Lett; 2015 Jun; 165(2):90-101. PubMed ID: 25929803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
    Hostettler KE; Zhong J; Papakonstantinou E; Karakiulakis G; Tamm M; Seidel P; Sun Q; Mandal J; Lardinois D; Lambers C; Roth M
    Respir Res; 2014 Dec; 15(1):157. PubMed ID: 25496490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effect of corticosteroids and long-acting beta(2)-agonists on serum- and TGF-beta(1)-induced extracellular matrix deposition by primary human lung fibroblasts.
    Goulet S; Bihl MP; Gambazzi F; Tamm M; Roth M
    J Cell Physiol; 2007 Jan; 210(1):167-76. PubMed ID: 17013807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endostatin inhibits fibrosis by modulating the PDGFR/ERK signal pathway: an in vitro study.
    Li Y; Ren HT
    J Zhejiang Univ Sci B; 2017 Nov.; 18(11):994-1001. PubMed ID: 29119737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo.
    Tao L; Cao J; Wei W; Xie H; Zhang M; Zhang C
    Int Immunopharmacol; 2017 Jun; 47():38-46. PubMed ID: 28364627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of TGF-β pathway by pirfenidone decreases extracellular matrix deposition in ocular fibroblasts in vitro.
    Stahnke T; Kowtharapu BS; Stachs O; Schmitz KP; Wurm J; Wree A; Guthoff RF; Hovakimyan M
    PLoS One; 2017; 12(2):e0172592. PubMed ID: 28231275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory effect of salvianolic acid B on TGF-β1-induced proliferation and differentiation in lung fibroblasts.
    Zhang M; Cao SR; Zhang R; Jin JL; Zhu YF
    Exp Lung Res; 2014 Apr; 40(4):172-85. PubMed ID: 24669910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of sesamin on airway fibrosis in vitro and in vivo.
    Lin CH; Shen ML; Kao ST; Wu DC
    Int Immunopharmacol; 2014 Sep; 22(1):141-50. PubMed ID: 24978608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis.
    Philp CJ; Siebeke I; Clements D; Miller S; Habgood A; John AE; Navaratnam V; Hubbard RB; Jenkins G; Johnson SR
    Am J Respir Cell Mol Biol; 2018 May; 58(5):594-603. PubMed ID: 29053339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine Receptor D1 Is Exempt from Transforming Growth Factor
    Gao AY; Diaz Espinosa AM; Nguyen BBN; Link PA; Meridew J; Jones DL; Gibbard DF; Tschumperlin DJ; Haak AJ
    J Pharmacol Exp Ther; 2023 Sep; 386(3):277-287. PubMed ID: 37024146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.